Viewing Study NCT06381765



Ignite Creation Date: 2024-05-06 @ 8:27 PM
Last Modification Date: 2024-10-26 @ 3:27 PM
Study NCT ID: NCT06381765
Status: COMPLETED
Last Update Posted: 2024-05-13
First Post: 2024-04-19

Brief Title: Serratus Plane Block and Pectointercostal Block
Sponsor: Cukurova University
Organization: Cukurova University

Study Overview

Official Title: Comparison of Deep Serratus Plane Block with Deep Serratus Plane BlockPectointercostal Plane Block
Status: COMPLETED
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: ASA I-II female patients aged over 18 who will undergoing breast reduction surgery will recruit to the study Patients will divide into 2 groups Deep serratus plane block will perform with 025 bupivacaine 20 ml at the midaxillary 5 rib bilaterally for Group I At Group II deep serratus plane block 025 bupivacaine 20 ml at the midaxillary 5th rib pectointercostal plane block 025 bupivacaine 15 ml at 4-5th intercostal space will perform bilaterally General anesthesia with sevoflurane and remifentanil will perform to the all patients Postoperative pain scores morphine consumption and complications will record till the 24th hours
Detailed Description: ASA I-II female patients aged over 18 who will undergoing breast reduction surgery will recruit to the study General anesthesia with sevoflurane and remifentanil will perform to the all patients Patients will divide into 2 groups Serratus plane block for group I and serratus plane blockpectointercostal block for Group II will perform bilaterally Ultrasound guided deep serratus plane block will perform with 025 bupivacaine 20 ml at the midaxillary 5 rib for Group I At Group II ultrasound guided deep serratus plane block 025 bupivacaine 20 ml at the midaxillary 5th rib pectointercostal plane block 025 bupivacaine 15 ml at 4-5th intercostal space will perform bilaterally Patient controlled analgesia will perform with Morphine 1 mg bolus 10 min lockout4 hours limit 10 mg at postoperative period Patients will evaluate with visual analogue scale VAS for postoperative pain scores till the first 24th hours Postoperative pain scores VAS morphine consumption and complications will record till the 24th hours

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None